On May 21, 2026, Vera Therapeutics, Inc. held its Annual Meeting where stockholders elected directors and ratified KPMG LLP as the accounting firm for 2026. The meeting saw 71.7 million shares eligible to vote, with significant support for the elected directors and the approved executive compensation.